• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外介导非那西丁O-脱乙基作用的人细胞色素P450:高亲和力成分作为CYP1A2活性指标的验证

Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity.

作者信息

Venkatakrishnan K, von Moltke L L, Greenblatt D J

机构信息

Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

出版信息

J Pharm Sci. 1998 Dec;87(12):1502-7. doi: 10.1021/js980255z.

DOI:10.1021/js980255z
PMID:10189256
Abstract

Phenacetin O-deethylation, widely used as an index reaction for cytochrome P450 1A2 (CYP1A2) activity, displays biphasic kinetics in human liver microsomes. CYP1A2 has been identified as contributing to the high affinity component, but is not verified as the sole contributor to the high affinity phase. In addition, the human CYP isoforms accounting for the low affinity phase have not been identified. We have used heterologously expressed human CYP isoforms to identify, kinetically characterize, and predict the relative contribution of the major human liver CYP isoforms mediating phenacetin O-deethylation. CYP1A2 (Km 31 microM) is the only high affinity phenacetin O-deethylase in human liver microsomes, while CYPs 2A6 (Km 4098 microM), 2C9 (Km 566 microM), 2C19 (Km 656 microM), 2D6 (Km 1021 microM), and 2E1 (Km 1257 microM) all contribute to the low affinity phase of the reaction. Considering the relative abundance of the various CYPs in human liver, CYP1A2 accounts for 86% of net reaction velocity at a substrate concentration of 100 microM, while CYP2C9 becomes the primary phenacetin O-deethylase at substrate concentrations of 865 microM and higher and accounts for 31% of the net Vmax of the reaction. Predictions from kinetic studies on heterologously expressed CYPs are consistent with chemical inhibition studies on human liver microsomes with sulfaphenazole and alpha-naphthoflavone that suggest a greater role for CYP2C9, and a smaller role for CYP1A2, at higher substrate concentrations. Thus CYP1A2 is the only high affinity human liver phenacetin O-deethylase, thereby validating the use of the high affinity component as an index of CYP1A2 activity in human liver microsomes.

摘要

非那西丁O - 脱乙基反应被广泛用作细胞色素P450 1A2(CYP1A2)活性的指标反应,在人肝微粒体中呈现双相动力学。CYP1A2已被确定为高亲和力组分的贡献者,但尚未被证实是高亲和力阶段的唯一贡献者。此外,导致低亲和力阶段的人CYP同工酶尚未被鉴定出来。我们利用异源表达的人CYP同工酶来鉴定、动力学表征并预测介导非那西丁O - 脱乙基反应的主要人肝CYP同工酶的相对贡献。CYP1A2(Km为31 microM)是人肝微粒体中唯一的高亲和力非那西丁O - 脱乙基酶,而CYP 2A6(Km为4098 microM)、2C9(Km为566 microM)、2C19(Km为656 microM)、2D6(Km为1021 microM)和2E1(Km为1257 microM)均对反应的低亲和力阶段有贡献。考虑到人肝中各种CYP的相对丰度,在底物浓度为100 microM时,CYP1A2占净反应速度的86%,而在底物浓度为865 microM及更高时,CYP2C9成为主要的非那西丁O - 脱乙基酶,占反应净Vmax的31%。对异源表达的CYPs进行动力学研究的预测结果与用磺胺苯吡唑和α - 萘黄酮对人肝微粒体进行化学抑制研究的结果一致,后者表明在较高底物浓度下,CYP2C9的作用更大,而CYP1A2的作用较小。因此,CYP1A2是唯一的高亲和力人肝非那西丁O - 脱乙基酶,从而验证了将高亲和力组分用作人肝微粒体中CYP1A2活性指标的用途。

相似文献

1
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity.体外介导非那西丁O-脱乙基作用的人细胞色素P450:高亲和力成分作为CYP1A2活性指标的验证
J Pharm Sci. 1998 Dec;87(12):1502-7. doi: 10.1021/js980255z.
2
Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.α-萘黄酮对人肝微粒体中非那西丁O-脱乙基酶活性的激活作用。
Xenobiotica. 1999 Sep;29(9):885-98. doi: 10.1080/004982599238137.
3
Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.人细胞色素P450 1A1和1A2底物及抑制剂探针的特异性
J Pharmacol Exp Ther. 1993 Apr;265(1):401-7.
4
Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine.CYP2C9和2C19对苯妥英4-羟基化作用的体外相对贡献:磺胺苯吡唑、奥美拉唑和噻氯匹定的抑制作用
Eur J Clin Pharmacol. 2001 Apr;57(1):31-6. doi: 10.1007/s002280100268.
5
Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.细胞色素P450 2E1作为一种低亲和力酶参与人肝微粒体中非那西丁O-脱乙基反应。
Drug Metab Dispos. 1999 Aug;27(8):860-5.
6
Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver.针对人细胞色素P450 1A2的抑制性单克隆抗体:人肝脏中对乙酰氨基酚O-脱乙基作用的分析
Pharmacogenetics. 1998 Oct;8(5):375-82. doi: 10.1097/00008571-199810000-00002.
7
Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A.多种人类细胞色素参与右美沙芬的体外生物转化:CYP2C9、CYP2C19、CYP2D6和CYP3A的作用。
J Pharm Pharmacol. 1998 Sep;50(9):997-1004. doi: 10.1111/j.2042-7158.1998.tb06914.x.
8
7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes.人肝微粒体中细胞色素P450 1A2和2E1催化的7-乙氧基香豆素O-脱乙基作用。
Biochem Pharmacol. 1996 Feb 9;51(3):313-9. doi: 10.1016/0006-2952(95)02178-7.
9
Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man.人体内负责阿地唑仑和N-去甲基阿地唑仑肝脏生物转化的酶的动力学特征及鉴定
J Pharm Pharmacol. 1998 Mar;50(3):265-74. doi: 10.1111/j.2042-7158.1998.tb06859.x.
10
Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2.右芬氟拉明在人肝微粒体及重组酶中的代谢:CYP2D6和1A2的作用
Pharmacogenetics. 1998 Oct;8(5):423-32. doi: 10.1097/00008571-199810000-00007.

引用本文的文献

1
Functional Characterization of 21 Rare Allelic Variants Identified in a Population of 4773 Japanese Individuals by Assessing Phenacetin -Deethylation.通过评估非那西丁去乙基化对4773名日本个体群体中鉴定出的21种罕见等位基因变体进行功能表征。
J Pers Med. 2021 Jul 22;11(8):690. doi: 10.3390/jpm11080690.
2
Fundamentals of Enzyme Kinetics: Michaelis-Menten and Non-Michaelis-Type (Atypical) Enzyme Kinetics.酶动力学基础:米氏动力学和非米氏型(非典型)酶动力学。
Methods Mol Biol. 2021;2342:3-27. doi: 10.1007/978-1-0716-1554-6_1.
3
Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective.
猪肝和肠药物代谢 CYP450 的特征:从定量、活性和选择性角度与人同源物比较。
Sci Rep. 2019 Jun 25;9(1):9233. doi: 10.1038/s41598-019-45212-0.
4
Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.盐酸纳曲酮对人肝微粒体细胞色素P450 1A2、2C9、2D6和3A4活性的影响。
Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):707-713. doi: 10.1007/s13318-018-0482-x.
5
Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study.华法林治疗患者中通过总夜间唾液咖啡因评估(TOSCA)对CYP 4501A2活性进行表型分析:一项横断面研究。
Clin Appl Thromb Hemost. 2018 Sep;24(6):928-935. doi: 10.1177/1076029617733040. Epub 2017 Oct 9.
6
Effects of Caffeic Acid and Quercetin on In Vitro Permeability, Metabolism and In Vivo Pharmacokinetics of Melatonin in Rats: Potential for Herb-Drug Interaction.咖啡酸和槲皮素对褪黑素在大鼠体内的体外通透性、代谢及体内药代动力学的影响:草药-药物相互作用的可能性
Eur J Drug Metab Pharmacokinet. 2017 Oct;42(5):781-791. doi: 10.1007/s13318-016-0393-7.
7
Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.肝细胞癌中细胞色素P450表达及活性严重受损与失调:对患者个体化治疗的意义
Mol Cancer Ther. 2015 Dec;14(12):2874-86. doi: 10.1158/1535-7163.MCT-15-0274. Epub 2015 Oct 29.
8
The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.常见药草提取物对CYP1A2、2C9、2C19和3A4的抑制活性及其对草药-药物相互作用的影响。
Afr J Tradit Complement Altern Med. 2014 Jun 4;11(4):54-61. doi: 10.4314/ajtcam.v11i4.9. eCollection 2014.
9
Hepatoprotective Effect of Pretreatment with Thymus vulgaris Essential Oil in Experimental Model of Acetaminophen-Induced Injury.黑种草精油预处理对醋氨酚诱导损伤实验模型的肝保护作用。
Evid Based Complement Alternat Med. 2014;2014:954136. doi: 10.1155/2014/954136. Epub 2014 Feb 4.
10
Structure of pyrazole derivatives impact their affinity, stoichiometry, and cooperative interactions for CYP2E1 complexes.吡唑衍生物的结构对其与 CYP2E1 复合物的亲和力、化学计量和协同相互作用有影响。
Arch Biochem Biophys. 2013 Sep 1;537(1):12-20. doi: 10.1016/j.abb.2013.06.011. Epub 2013 Jun 27.